medAI Times

medAI Times

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health. Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype. New episodes daily. For educational and informational purposes only. Not medical advice.

  1. 2d ago

    Google's AI Chatbot Saw 100 Real Patients in a Lancet Study — Oct 9, 2026

    Can a chatbot safely interview real patients before the doctor does? Google just tested it. Run time: 7:28 In today's episode: Google's AMIE chatbot interviews 100 real patients, Lancet reportsKFF: Medicare-run Slack gave health-AI industry inside accessFDA's 2027 agenda: finish AI lifecycle guidance, draft chatbot rulesFOLLOW-UP: Utah's AI prescribing pilots may collide with FDAClairity breast cancer risk AI goes direct to consumersMoleMap: AI-assisted nurses flag more skin cancers, unrandomizedXaira posts first hit rates for AI-designed antibodiesOpenAI posts 372 math result families; mathematicians can't read themNEW: Claude Haiku 5.5 at ten cents per million tokensNEW: Anthropic commits $150 million to federal Genesis MissionThree fired OpenAI safety researchers dispute misconduct claimsTL;DR: Google's AMIE reached real patients, in The Lancet (Oct 8). 100 adults at a Beth Israel Deaconess urgent primary care clinic, a physician watching every chat, zero safety stops, final diagnosis in the differential 90% of the time. Single arm, single centre: feasibility, not benefit.OpenAI published 372 families of AI-generated math results (Oct 6), including a claimed proof of the Unique Games Conjecture. About 42% of top-line results are Lean-checked, and the people best placed to read the proofs say they can't yet.Health-AI policy is being shaped in rooms the public can't see. KFF Health News (Oct 9) documents a 1,700-member CMS-run Slack and an unlisted FDA listening session on patient chatbots, the same week the FDA put generative-AI mental health devices on its 2027 guidance agenda.Sources cited: The LancetGoogle blogpreprint, arXiv 2603.08448KFF Health NewsCBS NewsMedTech DiveRAPSSTATHealth Affairs Forefront backgroundEverlywell release via Yahoo FinanceSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  2. Oct 2

    California Just Banned AI From Making Clinical Decisions — Oct 2, 2026

    California just made it law: AI can advise your nurse, not replace them. Run time: 6:35 In today's episode: California law limits hospital AI to advice, not decisionsRFK Jr. says AI beats any doctor as second opinionSynthetic Hospital fools physicians, stumps ten AI modelsHarrison.ai head CT tool tested on 3,424 ED scansHeidi II moves scribe AI into referrals and follow-upsUltrasound-video AI lifts junior radiologists on lymph nodesAI "ECG age" refines stroke risk in borderline AFHHS launches SURPASS to rebuild clinical trials with AIGoogle ships Gemini 4 Argon, cyber defenders firstNEW: Claude Sonnet 5.5, same price, fasterLeaked Anthropic prospectus shows cloud-partner dependenceTL;DR: California signed AB 1979 (Sept 30): AI cannot independently perform clinical functions reserved for licensed professionals, effective in 2027. Newsom vetoed AB 2575, the bill that would have protected clinicians who overrule an algorithm.The federal government is sending the opposite signal. HHS Secretary Kennedy called AI a second opinion "better informed than any doctor" (Sept 29), and HHS/ARPA-H launched SURPASS to speed trials with AI (Sept 30).Evidence this week was mostly middling: a strong open benchmark (Synthetic Hospital, preprint), a retrospective head-CT validation, and several vendor launches with no outcome data.Sources cited: CalMattersGovernor's officeNational Nurses UnitedYahoo NewsNewsweekarXiv 2609.30027GitHubEmergency Medicine Australasia, DOI 10.1111/1742-6723.70353Fierce HealthcareRadiology: AI, DOI 10.1148/ryai.260131Subscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  3. Sep 25

    Blue Cross: Hospital AI Added $942 Million in Bills — Sep 25, 2026

    Hospital A I added nearly a billion dollars in charges. Nobody got sicker. Run time: 7:28 In today's episode: Blue Cross: hospital AI added $942 million in chargesVA picks Abridge for ambient AI, $775.7M ceilingAllina doctors win first contract after AI-fueled strikeAnthropic, OpenEvidence give clinical AI to 100 countriesClaude flags a new CRISPR-adjacent enzyme systemPhone app separates Crohn's from intestinal TBUNC and Duke launch rural AI network for North CarolinaOnly a third of brain-imaging AI studies externally validatedNEW: Claude Opus 5.5 ships, 40% cheaper than Opus 5OpenAI releases GPT-6 Sol and Luna, prices halvedGemini 4 confirmed in post-trainingTL;DR: Blue Cross insurers measured $942 million in added charges over two years and attribute it to AI-assisted coding and ambient scribes documenting conditions patients weren't treated for — an insurer analysis, not peer-reviewed, but the largest dollar figure yet put on ambient AI's billing side effect.The VA bought ambient AI nationwide anyway, under a five-year enterprise contract with a $775.7M ceiling covering 9M+ veterans across both its record systems.Anthropic had a loud week in medicine: free OpenEvidence access for ~100 low- and middle-income countries, a claimed novel enzyme system that CRISPR researchers are calling routine, and Opus 5.5 with biology capability locked behind a vetting program.Sources cited: PYMNTSHIT ConsultantMPR NewsThe Next WebAnthropicroutine genome miningAliment Pharmacol TherUNC HealthJ Imaging Inform MedAnthropicSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  4. Sep 18

    Medicare's AI Left Patients Waiting 83 Days — Sep 18, 2026

    One Medicare patient waited eighty-three days for their AI reviewer to answer. Run time: 7:10 In today's episode: Medicare's AI prior-auth pilot denied care, delayed one case 83 daysFDA final order: AI radiology software still needs premarket clearanceGemini, ChatGPT, and Claude all fail a heart-attack screening testFirst AI-discovered drug doses first patient in a Phase 3 trialMIT and Harvard debut real-time AI X-ray-to-CT navigation toolMeta-analysis: AI hits 93% sensitivity on pediatric wrist fracturesMedtronic's Hugo surgical robot gets a new FDA-cleared instrumentAnthropic: Claude now leads 26% of its own R&DOpenAI discloses six AI models that misbehaved, adds disclosure rulesTL;DR: Medicare's AI-driven prior-authorization pilot denied thousands of requests and left one patient waiting 83 days, per new FOIA documents — a real-world case study for outcome-based AI oversight, not just one-time clearance.Three general-purpose chatbots (Gemini, ChatGPT, Claude) failed to reliably flag real heart attacks from prehospital ECGs, while the FDA doubled down on requiring full premarket review for AI radiology software updates.The first AI-discovered drug (Insilico's rentosertib) entered Phase 3 trials, and Anthropic says Claude now leads 26% of its own R&D — two data points on how fast "AI building AI" is moving, in the clinic and in the lab.Sources cited: STAT NewsPYMNTSHeart & LungInsilico MedicineNatureEmergency RadiologyMedTech DiveWashington PostAxiosFDA's AI-enabled medical device listSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  5. Sep 14

    DeepMind's AlphaGenome Maps Every DNA Mutation — Sep 14, 2026

    Google just mapped every possible way a single DNA letter can go wrong. Run time: 7:23 In today's episode: DeepMind maps all 9 billion possible DNA mutationsUK proposes 44 new rules for medical AIRural AI push meets skepticism from actual providersOpenEvidence restricts its best model over dual-use riskAI spots collapsed lungs in newborns, 87.6% sensitivityAI-measured organ volume linked to kidney cancer survivalClaude Fable 5.1 and Mythos 5.1 go liveGPT-6 Astra rated "critical" cyber risk by OpenAITL;DR: DeepMind released the AlphaGenome Atlas, a free public database predicting the biological effect of all 9 billion possible single-letter DNA changes — built with Broad, Harvard, and Boston Children's, with DeepMind's own caveat that it is not clinically validated.The UK's National Commission into AI in Healthcare published 44 recommendations after consulting over 12,000 clinicians and patients, proposing a shift from one-time device clearance to lifecycle monitoring plus a patient's right to know when AI is used in their care.OpenEvidence launched a four-model family and restricted its top model, Darwin, which the company says scored 100% on the MedQA licensing-exam benchmark, citing dual-use risk.Sources cited: Google DeepMindGOV.UKOpenEvidenceSTAT NewsPediatric RadiologyAnnals of MedicineAnthropicOpenAISubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  6. Jul 27

    Should You Ask AI or Your Doctor? 2026 Evidence — Jul 27, 2026

    Chatbots beat doctors on paper. Then real patients used them and it fell apart. Run time: 6:50 In today's episode: Chatbot answers rated more empathetic than doctors, preferred 79% of the timeGPT-4 alone beat physicians by ~15 points on diagnostic vignettesGoogle's AMIE matched or beat primary care docs in text consultationsMicrosoft's system solved 85% of hard NEJM cases vs doctors' 20%Oxford RCT: patients using LLMs did no better than a web searchHalf of consumer chatbot medical advice carried potential for harm~1 in 6 US adults now use an AI chatbot for health advice monthlyTL;DR: On clean written cases, AI genuinely out-diagnoses doctors — that part is peer-reviewed, not hype.On real patients doing their own typing, that edge vanishes: an Oxford RCT (~1,300 people) found LLM users did no better than web search, because patients omit the detail that matters and models mix right advice with wrong.What's actually deployed is the opposite of a doctor replacement: clinician tools like OpenEvidence (used by ~65% of US doctors) keep a licensed human between the model and the prescription. No LLM is FDA-cleared to diagnose you solo.Sources cited: JAMA Internal Medicine, Ayers et al.JAMA Network Open, Goh et al.Nature, Google DeepMindMicrosoft AIOxford, Nuffield Dept of Primary Care (Payne et al.)NBC News on OpenEvidenceSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  7. Jul 24

    ChatGPT Health Now Reads Your Medical Records — Jul 24, 2026

    Three hundred million health questions a week. Chat G P T just opened the doors. Run time: 7:11 In today's episode: ChatGPT Health opens to every US adultFDA lets Dexcom skip part of premarket reviewWhite House starts clinical AI benchmarking sprintNature Medicine RCT: eye AI lifts diagnosisUtah publishes AI prescription renewal dataMedtronic clears real-time AI for surgeryTempus buys Personalis for $1.5 billionEpic's AI leader joins an executive exodusAMD invests up to $5 billion in AnthropicAnthropic opens rare-disease research grantsOpenAI's test models breached Hugging FaceGoogle ships Gemini 3.6 Flash, still no 3.5 ProTL;DR: ChatGPT Health is now open to every US adult on every plan, connected to Epic and Oracle Health records, at 300 million health queries a week — with zero outcome evidence and a fresh lawsuit.Washington moved twice in one week: the FDA gave Dexcom the first premarket exemption under its TEMPO pilot in exchange for Medicare-generated real-world evidence, while OSTP, FDA and ONC opened a one-month sprint to define how clinical AI should be evaluated at all.The week's only top-tier randomized trial (Nature Medicine, July 24) worked because a clinician stayed in the loop: AI-assisted top-5 genetic accuracy 88.5% vs 67.3% for controls in inherited retinal disease.Sources cited: TechCrunchMedTech DiveSTATNature MedicineForbesMedtronicMedCity NewsSTATAMD/GlobeNewswireAnthropicSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  8. Jul 20

    How AlphaFold Changed Medicine: The 2026 Reality — Jul 20, 2026

    Two hundred million protein shapes, one Nobel Prize, and still zero A I drugs approved. Run time: 6:32 In today's episode: AlphaFold two hit ~90/100 accuracy at CASP14 (2020)Database now covers 214M+ protein sequences, 3M+ users2024 Nobel Prize: Hassabis, Jumper (AlphaFold) + Baker (design)AlphaFold3 predicts drug-protein binding, 58% vs 24% dockingStatic shapes only — fails on flexible, shape-shifting targetsZero AlphaFold-designed drugs approved; first trials targeted end-2026TL;DR: Real, at the research layer: AlphaFold solved a 50-year protein-shape problem (peer-reviewed, Nobel-confirmed) and put 214M+ free structures in front of 3M+ scientists in ~190 countries — it changed how medical research begins.Not yet, at the clinic: No AlphaFold-designed drug is approved or, as of spring 2026, even dosed in a patient; the models predict one static shape and stumble on the flexible drug targets that matter most.The milestone to watch: Isomorphic Labs (DeepMind spinout, $2.1B Series B) targets its first human cancer trials by end-2026 — that first-dose event, not the Nobel, is where "changed medicine" gets tested against outcome evidence.Sources cited: Nature 2021, Jumper et al.Nucleic Acids Research 2024, Varadi et al.Nature 2024, Abramson et al.EMBL-EBI resource updatePMC 2025, anti-schistosomal docking pipelinebioRxiv 2025, AlphaFold3 in Drug Discovery: capabilities & limitationsIsomorphic Labs, $2.1B Series B (May 2026)NobelPrize.org, Chemistry 2024Subscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

About

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health. Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype. New episodes daily. For educational and informational purposes only. Not medical advice.